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Bony calvariumA 58 years old woman was diagnosed with squamous cell carcinoma of the uterine cervix FIGO stage IIB and
was treated by concomitant radio-chemotherapy followed by simple hysterectomy. Severalmonths later a single
metastasis to the skull was diagnosed. The patient underwent craniotomy and radiotherapy and achieved a
prolonged disease free survival of 20 months.
Bonemetastases from cervical carcinoma are usually part of widespreadmetastatic disease. Skull metastases are
extremely rare. Selected cases of solitary bone metastases can be treated radically and achieve long term disease
free survival.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Squamous cell carcinoma of the cervix (SCC) is the second most
common malignancy in women in the developing world. It spreads
locally by direct extension and to the pelvic and extra-pelvic lymph
nodes. Hematogenous spread mainly occurs in patients whose disease
involved pelvic nodes. The most frequent sites of distant metastasis
are the lungs, extrapelvic nodes and liver. Bone metastases in cervical
cancer are uncommon. The exact frequency of bonemetastasis of cervi-
cal cancer is not known but is estimated to be in the range of 0.8%–23%
(Katz et al., 1979). These ranges differ mainly according to themethods
used to detect bone metastasis. The most frequent site for bone metas-
tasis is the vertebral column (Carlson et al., 1967) followed by the pelvis
and long bones (Baid et al., 1992). Metastasis to the bony calvarium is
extremely rare.
Metastatic cervical cancer is usually treated by chemotherapy, and
median survival in themost recent reports is about 13.3 months. Incor-
poration of bevacizumab to chemotherapy signiﬁcantly improved the
median overall survival to 17 months (Tewari et al., 2014).
However, in patients that present with a solitary disease site,
aggressive local treatment can sometimes result in prolonged sur-
vival. Selected cases with lung metastases can achieve long term re-
mission following pulmonary resection (Anderson et al., 2001). InelMedical Centers, 35 Rotchild
. This is an open access article underone report, the 5 year survival for patients who underwent pulmo-
nary metastastectomy was 46.8% (Anraku et al., 2004). Patients
with isolated recurrence in the paraaortic lymph nodes can be treat-
ed with concomitant chemo-radiotherapy and 5-year survival rates
between 30 and 50% have been reported (Chou et al., 2001). It
appears that asymptomatic paraaortic recurrence which is detected
by routine imagining carries a higher salvage rate than symptomatic
recurrence (Singh et al., 2005).
We report an unusual case of an isolated metastasis of cervical can-
cer to the fronto-parietal bone. The patient was treated by local surgery
and radiotherapy and remained disease free for 20 months.
Case description
A 58 year-old woman presented with postmenopausal bleeding and
was diagnosedwith squamous cell carcinoma of the uterine cervix FIGO
stage IIB. PET–CT was negative for lymph nodes metastases or distant
spread. She underwent concomitant chemo-radiotherapy to the pelvis
followed by intracavitary brachytherapy. PET–CT scan 8 months after
completion of initial therapy detected a small area of positive uptake
in the cervix without evidence of pelvic nodal involvement. Biopsies
from the cervix were non-conclusive and the patient underwent a
simple hysterectomy and bilateral salpingo-oophorectomy. Pathologi-
cal assessment did not reveal evidence of residual tumor. Physical ex-
amination and PET–CT 5 months later were negative for metastatic
disease.
Seven months after surgery the patient complained of headaches
and a fast growing lump on the right forehead. A lesion on her rightthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Bone scintigraphy demonstrating a solitary lytic lesion conﬁned solely to the fronto-parietal bone.
21A. Zilberlicht et al. / Gynecologic Oncology Reports 11 (2015) 20–22fronto-parietal bone was palpated and no neurologic deﬁcits were
noted. CT scan of the brain revealed a solitary lytic lesion conﬁned
solely to the fronto-parietal bone. Bone scintigraphy and Single-
photon emission computed tomography (SPECT) revealed the same
ﬁnding as well (Fig. 1). A whole body bone scan was negative for
other sites of metastasis. The patient underwent craniotomy and adju-
vant skull radiotherapy. Pathology ﬁndings were consistent with SCC
identical to the primary tumor (Fig. 2). The patient was well and freea: Core biopsy of metastac squamous cell carcinom
b:  Immunohistochemical stain for high molecular w
c: Immunohistochemical stain for surrogate high ris
Fig. 2.Histology specimens from patient's skull. a: Core biopsy of metastatic squamous cell carc
ular weight cytokeratin 5/6. Immunoperoxidase ×200. c: Immunohistochemical stain for surroof recurrent disease for 20 months, when metastases to the para-
aortic lymph nodes were diagnosed.
Discussion
Metastasis of cervical cancer to the skull is extremely rare. (Rath et
al., 2000) reported a case with multiple metastases to the scalp in a
patient treated with radiotherapy for a FIGO stage IIIB tumor. Yanuka of cervix. Hematoxylin-eosin, x200
eight cytokeran 5/6. Immunoperoxidase x200
k HPV marker p16. Immunoperoxidase x200
inoma of cervix. Hematoxylin–eosin, ×200. b: Immunohistochemical stain for highmolec-
gate high risk HPV marker p16. Immunoperoxidase ×200.
Table 1
Reported cases of solitary skull lesions of squamous cell carcinoma of the cervix.
Author Age Histology at the
time of diagnosis
FIGO
(stage)
Initial therapy Time till
relapse
(months)
Clinical presentation
at the time of relapse
Area of
metastasis
Number of
metastasis
Treatment at
the time of
recurrence
Vital status/
follow-up
Present study 58 SCC IIB Concomitant
radio-
chemotherapy
20 Headache, local
tenderness
Skull—parietal 1 Craniotomy and
radiotherapy
Alive⁎
Niloofar Ahmadloo
et al., 2010 (Mohanty
et al., 2010)
65 SCC IIIb Concomitant
radio-
chemotherapy
While
treated
Headache Bony calvarium Many Chemo radiation Died
Agarwal et al., 2002
(Pasricha et al., 2006)
60 SCC IIIb Radio +
brachytherapy
2 Local tenderness
and vaginal bleeding
Skull—
temporo-parietal
1 Radiotherapy Alive⁎
Abhishek et al.,
2008 (16)
53 Adenocarcinoma IIa Surgery +
radiotherapy
4 Local tenderness,
seizures
Frontal skull and
superior sagittal
sinus thrombosis
1 Chemo radiation Alive ⁎
Mohanty et al.,
2010 (17)
54 SCC IIIb Radio +
brachytherapy
2 Local tenderness Occipital lobe 1 Radiotherapy Alive⁎
⁎ At current time of publication of article.
22 A. Zilberlicht et al. / Gynecologic Oncology Reports 11 (2015) 20–22et al. (Yanuck et al., 1991) reported on a 21 year-old woman with stage
IV cervical cancer that presented with a mass on the frontal bone. Cases
with a solitary skull lesion are rare and only severalwere reported in the
English literature (Niloofar Ahmadloo et al., 2010; Agarwal et al., 2002;
Abhishek et al., 2008; Mohanty et al., 2010) (Table 1). In most of the
cases that have been described skull metastases developed after
treatment for advanced stage primary disease, reﬂecting the tenden-
cy of cervical cancer to spread to the lymphatic system before hema-
togenous spread occurs. In our unique case the clinical stage at
diagnosis was II-B and the scalp metastasis was diagnosed after a rel-
atively long (15 months) disease free interval.
The presenting symptoms of scalp metastases in the cases described
were headache or a palpablemass in the calvarium. The clinician should
be aware of this rare entity and its clinical presentation.
Skeletal metastasis from cervical carcinoma usually carries a poor
prognosis and life expectancy is less than twelvemonths after diagnosis,
regardless of the duration of disease free interval (Baid et al., 1992).
Treatment is usually directed toward maintaining quality of life and
includes local palliation with radiotherapy or surgery and systemic
chemotherapy. Treatment should be tailored according to the patient's
status.
As mentioned above, isolated recurrence of cervical cancer to the
lungs and paraaortic lymph nodes can be cured with radical therapy.
However, the appropriate therapy for a single bone metastasis has not
been deﬁned. Pasricha et al. described a case of solitary metastasis of
cervical cancer to the ﬁbula that was treated with surgery and radio-
therapy. After more than 3 years of follow-up the patient was free of
disease (Pasricha et al., 2006). In our case radical treatment also resulted
in a relatively prolonged (20 months) disease free survival, after which
another potentially curable recurrence in the para-aortic lymph nodes
was diagnosed. Notably, both cases developed after initial treatment
of a FIGO stage II primary disease.
Summary
This case highlights the need to address unusual symptoms in pa-
tients that have been treated for primary cervical cancer as this disease
may spread to unusual sites. Moreover, it demonstrates that selected
patients can achieve a long term disease free survival following radical
therapy for an isolated bone recurrence.Conﬂict of interest statement
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